Figure 2

Intravitreal ranibizumab in the management of acute central serous Chorioretinopathy

Ibrahim Nawaiseh, Ahmad Halawa* and Dina Alardah

Published: 24 November, 2017 | Volume 1 - Issue 1 | Pages: 049-054

ijceo-aid1007-g002

Figure 2:

OCT and thickness map of a patient at presentation (a), at 1 week (b), and at 2 months (c). The figure shows the improvement of central foveal thickness and eventual resolution of sub retinal fluid.

Read Full Article HTML DOI: 10.29328/journal.hceo.1001007 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?